SCHEMBL22567082

SCHEMBL22567082

CC1CCN(c2cccc3ccc(-n4cnc5cc(OCC6(C)COC6)ccc54)nc23)CC1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 3/20 0.86
FLT3 P36888 3/20 0.86
GAK O14976 1/20 0.86
RIPK2 O43353 1/20 0.86
ULK1 O75385 1/20 0.86
STK10 O94804 1/20 0.86
PRKD3 O94806 1/20 0.86
MAP4K4 O95819 1/20 0.86
LATS1 O95835 1/20 0.86
PAK4 O96013 1/20 0.86
NTRK1 P04629 1/20 0.86
LCK P06239 1/20 0.86
CDK1 P06493 1/20 0.86
APRT P07741 1/20 0.86
RET P07949 1/20 0.86
PDGFRB P09619 1/20 0.86
PHKG2 P15735 1/20 0.86
NQO2 P16083 1/20 0.86
PDGFRA P16234 1/20 0.86
FECH P22830 1/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Crenolanib SCHEMBL2730601 0.93 FLT3 (1.00) IRAK4FLT3GAKRIPK2ULK1
Crenolanib SCHEMBL29352568 0.93 FLT3 (1.00) IRAK4FLT3GAKRIPK2ULK1
Crenolanib SCHEMBL30002138 0.93 FLT3 (1.00) IRAK4FLT3GAKRIPK2ULK1
Crenolanib SCHEMBL29350134 0.93 FLT3 (1.00) IRAK4FLT3GAKRIPK2ULK1
SCHEMBL30775111 0.88 FLT3 (0.85) IRAK4FLT3GAKRIPK2ULK1
SCHEMBL27030604 0.88 FLT3 (0.85) IRAK4FLT3GAKRIPK2ULK1
SCHEMBL25249899 0.86 IRAK4 (0.75) IRAK4FLT3GAKRIPK2ULK1
SCHEMBL30775087 0.86 IRAK4 (0.75) IRAK4FLT3GAKRIPK2ULK1
SCHEMBL29450876 0.86 IRAK4 (0.75) IRAK4FLT3GAKRIPK2ULK1
Crenolanib SCHEMBL29361948 0.85 FLT3 (0.85) IRAK4FLT3GAKRIPK2ULK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3700516-B1 INHIBITORS OF DUX4 INDUCTION FOR REGULATION OF MUSCLE FUNCTION SONIC MASTER LTD (VG) 2024-01-24 EP disclosed
US-11065243-B2 Inhibitors of DUX4 induction for regulation of muscle function SONIC MASTER LIMITED (VG) 2021-07-20 US disclosed
US-20200330452-A1 Inhibitors of Dux4 Induction for Regulation of Muscle Function SONIC MASTER LIMITED (VG) 2020-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200330452-A1 Inhibitors of Dux4 Induction for Regulation of Muscle Function MUSK, MERTK, PRKDC IRAK4 306/4885FLT3 157/4885GAK 417/4885
US-11065243-B2 Inhibitors of DUX4 induction for regulation of muscle function MUSK, MERTK, PRKDC IRAK4 306/4885FLT3 157/4885GAK 417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.